Global S&T Development Trend Analysis Platform of Resources and Environment
With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies.
Some experts warn that accelerated testing will involve some risky trade-offs.
US authorities are failing to test people and notify their contacts, a cornerstone of outbreak response.
Scientists exposed to coronavirus: why weren'
Researchers warn production constraints and hoarding could limit SARS-CoV-2 vaccine supplies.